New Technology for DNA Typing - Bangalore Bio 2007

Bangalore, Karnataka, India

As the demands of scientists are increasing day by day for dependable Sequencing instruments, many new DNA sequencing instruments were discussed in one of the conference sessions of Bangalore Bio 2007 which will be cost effective and accurate in research, emphasizing the rapid ongoing progress in the field of R&D in India and the world over.

HistoGenetics has come up with Sequence Based Typing which has many advantages such as identifying many rare and new alleles. "Nearly 2000 alleles have been identified so far and it has been launched in the US and UK as of now" said Dr. Cereb Nezih, M.D., President and co-founder, Histogenetics, Inc.

"Many developing technologies with potential health benefits are becoming available to India. Sequencing data, essential for many of the medical breakthroughs of today and tomorrow, is currently accumulating at an exponential rate, largely because of advances in sequencing methods and laboratory automation. Instruments are available that can automate nearly every step in the large-scale sequencing process."

LABINDIA has come up with SOLiD: Sequencing by Oligonucleotide Ligation and Detection which is the Future of High Throughput Sequencing.

"This is useful for those who want to do full genome sequencing. Whole genome projects will be more cost effective with this new instrument than they are today," said Dr. Anupama Gaur, Team Leader Application Support, Labindia Instruments, Pvt. Ltd.

There have been tremendous advancements in genomic technologies. The technologies that are existent today have been there for many decades. The ImageStream multispectral imaging flow cytometry system can produce over 100,000 cell images per minute. This system allows you to have high resolution cell imaging and the advantage to do very advanced cell analysis. It will enable development of cost effective drugs.

"We can treat diseases by making drug discovery more efficient. This technology can be actively used in pharmaceuticals and it will have a big impact in research and clinical diagnostics", Mr. David Basiji. CEO, Amnis Corporation.

Source: Bangalore Bio 2007 (Business Wire India)

Press release presented here is sourced from the Source mentioned above and is provided on as-is basis. Please contact the Company / Source directly for any further information in regard to this release. This website will be unable to assist you in regard to the accuracy or correctness of information in this release.